VXRT
Income statement / Annual
Last year (2023), Vaxart, Inc.'s total revenue was $7.38 M,
an increase of 6,796.26% from the previous year.
In 2023, Vaxart, Inc.'s net income was -$82.47 M.
See Vaxart, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$7.38 M
|
$107,000.00
|
$892,000.00
|
$4.05 M
|
$9.86 M
|
$4.16 M
|
$5.84 M
|
$8.90 M
|
$9.30 M
|
$24.60 M
|
| Cost of Revenue |
$68.14 M |
$3.27 M |
$48.75 M |
$19.86 M |
$14.54 M |
$17.28 M |
$12.36 M |
$17.63 M |
$100,000.00 |
$3.60 M |
| Gross Profit |
-$60.76 M |
-$3.16 M |
-$47.86 M |
-$15.82 M |
-$4.68 M |
-$13.12 M |
-$6.52 M |
-$8.73 M |
$9.20 M |
$21.00 M |
| Gross Profit Ratio |
-8.23 |
-29.53 |
-53.65 |
-3.91 |
-0.47 |
-3.15 |
-1.12 |
-0.98 |
0.99 |
0.85 |
| Research and Development
Expenses |
$68.14 M
|
$81.05 M
|
$48.75 M
|
$19.86 M
|
$14.54 M
|
$17.28 M
|
$12.36 M
|
$28.30 M
|
$26.30 M
|
$19.80 M
|
| General & Administrative
Expenses |
$22.58 M
|
$29.39 M
|
$21.89 M
|
$15.20 M
|
$6.19 M
|
$6.68 M
|
$2.60 M
|
$5.70 M
|
$5.60 M
|
$6.60 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$22.58 M
|
$29.39 M
|
$21.89 M
|
$15.20 M
|
$6.19 M
|
$6.68 M
|
$2.60 M
|
$5.70 M
|
$5.60 M
|
$6.60 M
|
| Other Expenses |
$0.00 |
$6.96 M |
$3.79 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$200,000.00 |
$100,000.00 |
$300,000.00 |
| Operating Expenses |
$90.73 M |
$110.44 M |
$70.64 M |
$35.07 M |
$20.73 M |
$23.96 M |
$83,000.00 |
$36.30 M |
$34.30 M |
$29.20 M |
| Cost And Expenses |
$90.73 M |
$110.44 M |
$70.64 M |
$35.07 M |
$20.73 M |
$23.96 M |
$12.44 M |
$36.30 M |
$34.30 M |
$32.80 M |
| Interest Income |
$2.65 M |
$1.25 M |
$81,000.00 |
$75,000.00 |
$149,000.00 |
$58,000.00 |
$2.98 M |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$1.45 M |
$1.31 M |
$1.48 M |
$1.87 M |
$2.39 M |
$2.68 M |
$0.00 |
$1.80 M |
$300,000.00 |
$0.00 |
| Depreciation &
Amortization |
$8.62 M
|
$3.27 M
|
$2.43 M
|
$1.85 M
|
$3.60 M
|
$3.20 M
|
$380,000.00
|
$100,000.00
|
$100,000.00
|
$1.10 M
|
| EBITDA |
-$74.72 M
|
-$103.12 M
|
-$66.45 M
|
-$28.26 M
|
-$12.17 M
|
-$12.02 M
|
-$8.74 M
|
-$27.20 M
|
-$25.00 M
|
-$18.10 M
|
| EBITDA Ratio |
-10.13 |
-900.2 |
-69.14 |
-6.98 |
-0.72 |
-3.98 |
-1.5 |
-3.04 |
-2.67 |
-0.28 |
| Operating Income Ratio
|
-11.3
|
-1070.91
|
-81.56
|
-7.46
|
-1.6
|
-5.23
|
-1.56
|
-3.09
|
-2.71
|
-0.79
|
| Total Other
Income/Expenses Net |
$1.14 M
|
$6.90 M
|
$2.39 M
|
-$1.81 M
|
-$2.37 M
|
$3.86 M
|
-$467,000.00
|
-$1.70 M
|
-$200,000.00
|
$300,000.00
|
| Income Before Tax |
-$82.20 M |
-$107.69 M |
-$70.36 M |
-$31.98 M |
-$18.16 M |
-$17.90 M |
-$9.58 M |
-$29.10 M |
-$25.40 M |
-$19.20 M |
| Income Before Tax Ratio
|
-11.14
|
-1006.46
|
-78.88
|
-7.9
|
-1.84
|
-4.3
|
-1.64
|
-3.27
|
-2.73
|
-0.78
|
| Income Tax Expense |
$261,000.00 |
$67,000.00 |
$107,000.00 |
$238,000.00 |
$490,000.00 |
$109,000.00 |
$2.88 M |
$300,000.00 |
$400,000.00 |
-$100,000.00 |
| Net Income |
-$82.47 M |
-$107.76 M |
-$70.47 M |
-$32.22 M |
-$18.65 M |
-$18.01 M |
-$12.46 M |
-$29.40 M |
-$25.40 M |
-$19.10 M |
| Net Income Ratio |
-11.18 |
-1007.08 |
-79 |
-7.96 |
-1.89 |
-4.33 |
-2.13 |
-3.3 |
-2.73 |
-0.78 |
| EPS |
-0.57 |
-0.84 |
-0.58 |
-0.36 |
-0.86 |
-2.85 |
-3.29 |
-8.37 |
-7.23 |
-5.94 |
| EPS Diluted |
-0.57 |
-0.84 |
-0.58 |
-0.36 |
-0.86 |
-2.85 |
-2.83 |
-8.37 |
-7.23 |
-5.94 |
| Weighted Average Shares
Out |
$144.82 M
|
$127.68 M
|
$121.45 M
|
$88.30 M
|
$21.57 M
|
$6.32 M
|
$3.78 M
|
$3.51 M
|
$3.51 M
|
$3.21 M
|
| Weighted Average Shares
Out Diluted |
$144.82 M
|
$127.68 M
|
$121.45 M
|
$88.30 M
|
$21.57 M
|
$6.32 M
|
$4.41 M
|
$3.51 M
|
$3.51 M
|
$3.21 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
